Skip to main content
. 2019 Dec 16;200(1):33–44. doi: 10.1111/cei.13403

Figure 3.

Figure 3

The repertoire of immunosuppressive molecules expressed in glioblastoma (GBM). (a) Expression of selected cell surface antigens on GBM stem‐like cell (GSC) lines; the data show expression by GBM20. A summary of expression across the four GSC lines is provided in Supporting information, Table S1. (b) Single‐cell (sc) RNAseq data [18] were clustered, revealing immune and tumour groups marked by protein tyrosine phosphatase receptor type C (PTPRC) and SRY‐box transcription factor 9 (SOX9/EGFR co‐expression, respectively. Expression of marker genes for cell lineages and those encoding immunomodulatory molecules are indicated. Expression is scored according to the values and key shown.

HHS Vulnerability Disclosure